$AVAH

Third-quarter results are due before markets open Nov. 12; Aveanna's call follows at 10 a.m. Eastern.

Aveanna Healthcare (AVAH) will release Q3 results on Nov. 12, 2026, before market open, followed by a conference call at 10 a.m. ET. The call and webcast can be accessed live or replayed later. Aveanna provides healthcare services across 39 states, focusing on pediatric and adult care.

Original reporting
Published Oct 22, 2026, 10:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AVAH
Neutral
high confidence
Mentioned
$AVAH
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AVAHNeutralMed
01

Why it matters

The earnings release date announcement is a routine but material catalyst that can drive short‑term price movement.

02

Market read

Investors will watch the Nov 12 earnings for guidance on revenue growth and margins, influencing sector sentiment.

03

What to watch

Potential regulatory changes or payer contract updates that could be discussed during the call.

Relevance 5/10Novelty 5/10Timing: pre‑market on Nov 12, 2026

Background

Aveanna Healthcare provides pediatric and adult home health services across the US and is scheduled to release its Q3 results.

Company-level read

Ticker impact

$AVAHNeutralHigh confidence
Context

Aveanna Healthcare announced the date and time for its Q3 earnings release and conference call.

Expected impact

likely heightened volatility with potential upside or downside depending on the earnings surprise.

Evidence & confidence

Earnings date announcements are standard catalysts; the market will react once results are posted.

Market effects

May affect the broader healthcare services sector as peers are compared to Aveanna's upcoming results.

US healthcare market focus; limited regional spillover.

Low global impact beyond sector peers.

Counterpoint

If the market has already priced in strong earnings, the announcement could trigger a sell‑off on disappointment.

Key entities

  • Aveanna Healthcare Holdings Inc.

    Provider of pediatric and adult healthcare services, ticker AVAH.

Related articles

$AVAHMedAI 8/10

Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight

Aveanna Healthcare (AVAH) reported Q2 revenue of $670M, up 13.7% YoY, with all divisions growing. CEO Shaner announced a pediatric nursing rate increase in California starting 2027. Adjusted EBITDA rose 8% to $95.4M. The company raised full-year guidance to over $2.68B in revenue and $365M in adjusted EBITDA. However, private duty services saw higher costs per hour, and some growth was due to nonrecurring items.

$AVAHHighAI 8/10

Why is Aveanna Healthcare stock sliding today?

Aveanna Healthcare (AVAH) stock fell 7.6% in pre-market trading after existing shareholders, including J.H. Whitney Equity Partners and insiders, sold 15 million shares at $11.75, a discount to the prior close. The underwriter has a 30-day option to sell more shares, adding supply pressure. The company itself is not selling shares or receiving proceeds. The broader U.S. market is higher in pre-market.